Corient Private Wealth’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Sell
47,665
-5,553
-10% -$487K 0.01% 984
2026
Q1
$4.76M Buy
53,218
+6,229
+13% +$572K 0.01% 867
2025
Q4
$4.23M Buy
46,989
+4,863
+12% +$461K 0.01% 830
2025
Q3
$4.15M Sell
42,126
-10,420
-20% -$1.03M 0.01% 778
2025
Q2
$4.79M Sell
52,546
-6,214
-11% -$601K 0.01% 712
2025
Q1
$6.65M Sell
58,760
-14,156
-19% -$1.51M 0.01% 606
2024
Q4
$7.7M Sell
72,916
-19,761
-21% -$2.12M 0.01% 577
2024
Q3
$10M Buy
92,677
+26,261
+40% +$2.87M 0.02% 561
2024
Q2
$7.21M Sell
66,416
-203
-0.3% -$23.9K 0.01% 605
2024
Q1
$8.79M Buy
66,619
+2,111
+3% +$264K 0.02% 560
2023
Q4
$7.85M Buy
64,508
+3,230
+5% +$360K 0.01% 579
2023
Q3
$6.88M Buy
61,278
+4,835
+9% +$614K 0.02% 565
2023
Q2
$8.22M Sell
56,443
-4,300
-7% -$584K 0.02% 502
2023
Q1
$7.85M Buy
60,743
+27,418
+82% +$3.44M 0.02% 472
2022
Q4
$4.25M Buy
+33,325
New +$3.87M 0.02% 535

Other funds holding ZBH

Corient Private Wealth's ZBH Position: Q2 2026 in Review

Corient Private Wealth reduced its Zimmer Biomet (ZBH) stake by 10% in Q2 2026, selling an estimated $487K and leaving 47,665 shares worth $4.1M. The position accounts for 0.01% of the portfolio, ranked #984.

Corient Private Wealth first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $10M in Q3 2024. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Corient Private Wealth held 47,665 shares of Zimmer Biomet worth $4.1M as of Q2 2026.
  • Corient Private Wealth sold 5,553 Zimmer Biomet shares in Q2 2026, an estimated $487K.
  • Zimmer Biomet made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #984 holding.
  • Corient Private Wealth first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Zimmer Biomet position peaked at $10M in Q3 2024.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.